Journals / Çocuk Dergisi / 2004 / Cilt: 4 - Sayı: 4

Kostmann syndrome: A case report

Kostmann sendromu: Vaka sunumu

Pages
264–266
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this paper, we present 16-months-old boy with a history of recurrent bacterial infections starting in early infancy and discuss the clinical features of Kostmann Syndrome.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Kostmann Syndrome, severe congenital neutropenia, is characterized by an arrest in myeloid maturation at the promyelocyte stage of bone marrow, resulting in an absolute neutrophil count of less than 200/mm3.
📊
Key Findings & Data:The availability of recombinant human granulocyte colony stimulating factor (r-HuG-CSF) in 1987 dramatically changed both the prognosis of neutropenia and the quality of life of patients.
💡
Conclusion & Impact:In this paper, we present 16-months-old boy with a history of recurrent bacterial infections starting in early infancy and discuss the clinical features of Kostmann Syndrome.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Bakteriyel enfeksiyonlar · Çocuk · Nötropeni

Abstract

Kostmann Syndrome, severe congenital neutropenia, is characterized by an arrest in myeloid maturation at the promyelocyte stage of bone marrow, resulting in an absolute neutrophil count of less than 200/mm3. Patients suffer from severe bacterial infections. The availability of recombinant human granulocyte colony stimulating factor (r-HuG-CSF) in 1987 dramatically changed both the prognosis of neutropenia and the quality of life of patients. In this paper, we present 16-months-old boy with a history of recurrent bacterial infections starting in early infancy and discuss the clinical features of Kostmann Syndrome.

Özet

Kostmann Sendromu, ağır konjenital nötropeni, kemik iliğinde miyelosit olgunlaşmasının promyelosit aşamasında duraklaması ile karakterize, mutlak nötrofil sayısının 200 /mm3'den az olması ile sonuçlanan bir hastalıktır. Hastalarda ciddi bakteriyel infeksiyonlar görülür. 1987'de rekombinan insan granulosit koloni stimulating faktörün (r-HuG-CSF) kullanılır olmasıyla nötropeninin prognozu ve hastaların yaşam kalitesi belirgin olarak değişmiştir. Bu yazıda sütçocukluğu döneminde başlayan tekrarlayan bakteriyel infeksiyonlar öyküsü olan 16 aylık erkek hasta Kostmann sendromunun klinik özelliklerini tartışmak amacıyla sunuldu.

🔖

Cite This Article

ÇELİK, Y., SALİHOĞLU, B., HATİPOĞLU, S., KARADAĞ, A., ARICA, V. (2004). Kostmann syndrome: A case report. Çocuk Dergisi, Cilt: 4 - Sayı: 4, 264–266. https://ajindex.com/articles/194999

References (1)

  1. Kostmann R. Infantile genetic agranulocytosis. Acta Pediatr Scand 1956; 45: 1. 2.Kostmann R. Infantile genetic agranulocytosis: a review with presentation of ten cases. Acta Pediatr Scand 1975; 64: 362. 3.Ziedler C, Welte K. Kostmann syndrome and severe congenital neutropenia.Semin Hematol 2002; 39: 82-8. 4.Severe Congenital Neutropenia or Kostmann Syndrome http://depts.washington.edu/registry/Kostmann.htm. 5.Behrman RE, Kliegman RM, Jenson HB. Leukopenia. Nelson Textbook of Pediatrics, 16th ed. Philadelphia: WB Saunders Company, 2000: 624-5. 6.Ziedler C, Welte K, Barak Y, et al. Stem cell transplantation patients with severe congenital neutropenia without evidence of leucemic transformation Blood 2000: 95: 1195-8. 7.Sıdal M, Vardar F, Özkınay C. Nötropenik hastaya yaklaşım. Türkiye Klinikleri 2004; 2: 307-17. 8.Ziedler C, Schwinzer B, Welte K. Congenital Neutropenias. Rev Clin Exp Hematol 2003; 7: 72-83. 9.Welte K, Dale D. Pathophysiology and treatment of severe chronic neutropenia. Ann Hematol 1996; 72: 158-65. 10.Dale DC, Cottle TE, Fier CJ, et al. Severe chronic neutropenia: Treatment and follow-up of pateints in the Severe Chronic Neutropenia International Registry. Am J Hematol 2003; 72: 82-93. 11.Freedman MH, Bonilla MA, Fier C, et al. Myelodisplasia syndrome and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy. Blood, 200; 96: 429-36.